Opko Health【OPK】銘柄情報

Opko Health Inc (OPK) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.45

( - )

買値

1.40

売値

1.45

出来高

1,763,724

1.415 日の範囲 1.48

0.9769 52 週間の範囲 1.60

時価総額

1.095B

前日終値

1.45

始値

1.45

時刻

942

1.45

(formt)

最終取引時間

財務取引量

US$ 2,537,260

VWAP

1.4386

平均取引量 (3 か月)

US$ 2,590,278

発行済株式数

755,092,256

配当利回り

PER

-5.23

1 株当たり利益 (EPS)

-0.28

歳入

581.12M

純利益

-212.92M

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types o... OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

www.opko.com

本社

Miami, United States

設立

2026

Opko Health Inc is listed in the Healthcare sector of the ナスダック市場 with ticker OPK. The last closing price for Opko Health was US$1.45. Over the last year, Opko Health shares have traded in a share price range of US$ 0.9769 to US$ 1.60.

Opko Health currently has 755,092,256 shares in issue. The market capitalisation of Opko Health is US$1.09 billion. Opko Health has a price to earnings ratio (PE ratio) of -5.23.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic B-cell...

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) today announced that its...

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- BioReference® Health LLC, an OPKO Health, Inc. company...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.02	-1.36054421769	1.47	1.55	1.4	2432589	1.44010157	CS
4	0.37	34.2592592593	1.08	1.55	1.075	2964094	1.35400843	CS
12	0.29	25	1.16	1.55	0.9769	2591170	1.22713948	CS
26	0.06	4.31654676259	1.39	1.55	0.9769	2850983	1.25203597	CS
52	0.12	9.02255639098	1.33	1.6	0.9769	2738387	1.30714966	CS
156	-0.12	-7.64331210191	1.57	2.24	0.8516	4263585	1.32790966	CS
260	-2.27	-61.0215053763	3.72	5.25	0.8516	4011445	1.89636841	CS